Navigation Links
Mallinckrodt Pharmaceuticals And Questcor Pharmaceuticals Provide Update On Transaction
Date:7/14/2014

stcor operate; the commercial success of Mallinckrodt's and Questcor's products, including H.P. Acthar® Gel; Mallinckrodt's and Questcor's ability to protect intellectual property rights; the parties' ability to satisfy the merger agreement conditions and consummate the merger on the anticipated timeline or at all; the availability of financing, including the financing contemplated by the debt commitment letter, on anticipated terms or at all; Mallinckrodt's ability to successfully integrate Questcor's operations and employees with Mallinckrodt's existing business; the ability to realize anticipated growth, synergies and cost savings; Questcor's performance and maintenance of important business relationships; the lack of patent protection for Acthar, and the possible United States Food and Drug Administration ("FDA") approval and market introduction of additional competitive products; Questcor's reliance on Acthar for substantially all of its net sales and profits; Questcor's ability to continue to generate revenue from sales of Acthar to treat on-label indications associated with nephrotic syndrome, multiple sclerosis, infantile spasms or rheumatology-related conditions, and Questcor's ability to develop other therapeutic uses for Acthar; volatility in Questcor's Acthar shipments, estimated channel inventory, and end-user demand; an increase in the proportion of Questcor's Acthar unit sales comprised of Medicaid-eligible patients and government entities; Questcor's research and development risks, including risks associated with Questcor's work in the areas of nephrotic syndrome and lupus, and Questcor's efforts to develop and obtain FDA approval of Synacthen Depot; Mallinckrodt's ability to receive procurement and production quotas granted by the U.S. Drug Enforcement Administration; Mallinckrodt's ability to obtain and/or timely transport molybdenum-99 to its technetium-99m generator production facilities; customer concentration;
'/>"/>
SOURCE Mallinckrodt plc
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
2. Abbott to Sell its Developed Markets Branded Generics Pharmaceuticals Business to Mylan
3. Rock Creek Pharmaceuticals Issues Update On US Investigational New Drug Application
4. Valeant Pharmaceuticals Completes Sale Of Filler And Toxin Assets To Galderma
5. Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc.
6. Isis Pharmaceuticals to Receive $7.5 Million from Alnylam
7. Cadence Pharmaceuticals Estimates Fourth Quarter and Full Year 2013 Product Revenue and Provides Full Year 2014 Revenue Guidance
8. Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness
9. Avanir Pharmaceuticals Pre-announces Preliminary Fiscal 2014 First Quarter Financial Information
10. Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aegerion Pharmaceuticals, Inc.
11. Crealta Pharmaceuticals LLC Announces Completion of the Acquisition of Substantially All of the Assets of Savient Pharmaceuticals, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... MALVERN, Pa. , May 29, 2015 /PRNewswire-USNewswire/ ... major focus of the Association for the Advancement ... 1995. With support from AAWC,s corporate ... Educational Portal on the AAWC website ... on a wound care pathway with links to ...
(Date:5/28/2015)... NEW YORK , May 28, 2015 ... billions developing new drugs and tests, and ... for the instruments that can assist them. This ... research publisher. Kalorama Information said instruments such as ... can assist in the identification of drug ...
(Date:5/28/2015)... , May 28, 2015  IRIDEX Corporation (NASDAQ: IRIX ... Officer James H. Mackaness is scheduled to present ... at 9:00 am PT in Los Angeles ... may be accessed on the Event Calendar of the Investors ... of the webcast will be available shortly after the conclusion ...
Breaking Medicine Technology:The Association for the Advancement of Wound Care Educates the Public 2Report: Proteomics Research Market Reaches $1.6 Billion 2Report: Proteomics Research Market Reaches $1.6 Billion 3
(Date:5/29/2015)... Healthpointe is now offering pain ... therapy, and injections , For patients throughout Southern ... back pain, Healthpointe has a team of experts ... disc protrusions and other causes of back ... of renowned surgeons are now treating osteoarthritis, spinal ...
(Date:5/29/2015)... Dr. Rodger Murphree, author of ... is now offering free weekly call in teleconferences ... ways to reduce symptoms associated with fibromyalgia including ... brain fog. , To find out more ... call in teleconferences simply go to http://www.endfibronow.com ...
(Date:5/29/2015)... 29, 2015 Healthpointe’s electromyography and ... the Los Angeles County clinics including its newest ... now being offered at all Healthpointe locations throughout ... San Bernardino County. , As the muscles ... send electrical impulses throughout the body and dictate ...
(Date:5/29/2015)... 2015 This is a professional ... the Naproxen industry.The report provides a basic overview ... industry chain structure. The Naproxen market ... development trends, competitive landscape analysis, and key regions ... well as manufacturing processes and cost structures are ...
(Date:5/29/2015)... Dallas, TX (PRWEB) May 29, 2015 ... Pipeline Review, H1 2015” provides comprehensive information ... The report strengthens R&D pipelines by identifying ... and best-in-class products. Complete report on H1 ... 18 market data tables and 13 figures, ...
Breaking Medicine News(10 mins):Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3Health News:Healthpointe Is Now Offering EMG and NCV Diagnostics at All Clinics throughout Southern California. 2Health News:Naproxen Market Analysis For Global & China Regions 2020 Research Forecasts 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 2Health News:Axillary Hyperhidrosis Therapeutic Assessment Pipeline Review H1 2015 Market Research Report Available at RnRMarketResearch.com 3
... 2008 (March 24), the Infectious Diseases Society of America ... U.S. policymakers to step up the fight against tuberculosis ... home and abroad. , With drug-resistant strains of TB ... on the decline, resources are needed to support TB ...
... OVERLAND PARK, Kan., March 20 A recent ... a strong reminder to,horse owners throughout the country ... mosquito-borne diseases. To ensure your horse receives,the most ... Nile-,Innovator(R)+EWT -- "The Mosquito Shot," the only vaccine ...
... Experience , KENNEBUNK, Maine, March 20 ... body care, announced a patent-pending breakthrough formula,in its ... Sensitive Care,Toothpastes., (Photo: http://www.newscom.com/cgi-bin/prnh/20080320/NETH004 ), ... cofounder & CEO of Tom,s of Maine, announced ...
... Dreier LLP (http://www.dreierllp.com ),announces that a ... District,Court for the District of Massachusetts on behalf ... the "Company"),(Nasdaq: VRTX ) publicly traded securities ... 2, 2007, inclusive (the "Class Period"). The,Complaint alleges ...
... Mass., March 20 Alseres,Pharmaceuticals, Inc. (Nasdaq: ... a,Third Amended and Restated Convertible Promissory Note Purchase ... L. Gipson, Thomas Gipson, Arthur,Koenig, Ingalls & Snyder ... "Purchaser"). The agreement provides for the Company to ...
... Response Biomedical,Corporation (TSX: RBM, OTCBB: RPBIF) today ... new state-of-the-art global headquarters located at 1781 ... March 31, 2008., The 46,000 square ... and constructed for development and GMP manufacturing,and ...
Cached Medicine News:Health News:ID, HIV experts urge more resources for TB 2Health News:Fort Dodge's 'Mosquito Shot' Offers Convenient Protection Against Dangerous Mosquito-Borne Illnesses 2Health News:Tom's of Maine Introduces a Patent-Pending New Formula with the Launch of its Natural Clean & Gentle Care and Sensitive Care Toothpastes 2Health News:Tom's of Maine Introduces a Patent-Pending New Formula with the Launch of its Natural Clean & Gentle Care and Sensitive Care Toothpastes 3Health News:Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX) 2Health News:Dreier LLP Announces Class Action Lawsuit Against Vertex Pharmaceuticals Incorporated (VRTX) 3Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 2Health News:Alseres Pharmaceuticals, Inc. Raises $5 Million 3Health News:Response Biomedical Corporation Moves to New Facility 2Health News:Response Biomedical Corporation Moves to New Facility 3Health News:Response Biomedical Corporation Moves to New Facility 4
The Bio-Quant CK-MB test is an immunochromatography based one step in vitro test. It is designed for qualitative determination of,CK-MB in human serum specimens as an aid in the diagnosis of myocar...
... an all new, completely re-engineered high performance PTCA ... LOWEST CROSSING PROFILE PTCA products available at ... of only 0.17. Atriums all new HyperLite LX ... ever!, ,Atriums new "Dura-Blend tip technology is a ...
... Through its unique and patented design, ... and trunk cables between patients and ... allowing freedom of movement throughout the ... the LifeSync(R) System employs two-way radios ...
... in vitro assay for detection of alpha ... is a protein with molecular mass ranging ... concentration in serum is below 9 ng/mL; ... ovarian, testicular and presacral teratocarcinomas, and other ...
Medicine Products: